Baidu
map

血管外科指南

订阅

MedSci主页 / 所有栏目 / 血管外科指南

2017年ESC外周动脉疾病诊断治疗指南解读—下肢动脉疾病篇

2017-12-30 中国循证医学杂志.2017,17(12):1381-1387.

外周动脉疾病

本文对 2017 年欧洲心脏病学会年会（European Society of Cardiology，ESC）外周动脉疾病诊断治疗指南中关于下肢动脉疾病的内容进行解读，以期为临床实践提供借鉴。

中文标题：

2017年ESC外周动脉疾病诊断治疗指南解读—下肢动脉疾病篇

发布机构：

发布日期：

2017-12-30

简要介绍：

本文对 2017 年欧洲心脏病学会年会（European Society of Cardiology，ESC）外周动脉疾病诊断治疗指南中关于下肢动脉疾病的内容进行解读，以期为临床实践提供借鉴。

作者： 四川大学华西医院血管外科 袁丁 赵纪春 马玉奎 王铁皓 黄斌 杨轶

 

拓展指南：与动脉相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=2017年ESC外周动脉疾病诊断治疗指南解读—下肢动脉疾病篇)] GetToolGuiderByIdResponse(projectId=1, id=db3211c0015a631c, title=2017年ESC外周动脉疾病诊断治疗指南解读—下肢动脉疾病篇, enTitle=, guiderFrom=中国循证医学杂志.2017,17(12):1381-1387., authorId=null, author=, summary=本文对 2017 年欧洲心脏病学会年会（European Society of Cardiology，ESC）外周动脉疾病诊断治疗指南中关于下肢动脉疾病的内容进行解读，以期为临床实践提供借鉴。 , cover=, journalId=null, articlesId=null, associationId=null, associationName=, associationIntro=, copyright=0, guiderPublishedTime=Sat Dec 30 00:00:00 CST 2017, originalUrl=, linkOutUrl=, content=<P>本文对 2017 年欧洲心脏病学会年会（European Society of Cardiology，ESC）外周动脉疾病诊断治疗指南中关于下肢动脉疾病的内容进行解读，以期为临床实践提供借鉴。 </P>作者： 四川大学华西医院血管外科 袁丁 赵纪春 马玉奎 王铁皓 黄斌 杨轶 <P> </P>拓展指南：<strong>与<font color=red>动脉</font>相关指南：</strong><br><ul><li><a href="//m.capotfarm.com/guideline/show_article.do?id=08e701c0015a4621" title="2018 ASNR指南：颈动脉壁影像学检查" target=_blank>2018 ASNR指南：颈动脉壁影像学检查</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=f24a71c0015362a1" title="2017 SVS实践指南：腹主动脉瘤患者的护理" target=_blank>2017 SVS实践指南：腹主动脉瘤患者的护理</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=828641c001532397" title="经导管动脉灌注化疗药物应用原则—中国肿瘤介入专家共识" target=_blank>经导管动脉灌注化疗药物应用原则—中国肿瘤介入专家共识</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=886511c001512508" title="心脏冠状动脉CT血管成像技术规范化应用中国指南" target=_blank>心脏冠状动脉CT血管成像技术规范化应用中国指南</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=648d61c001501267" title="中国冠状动脉杂交血运重建专家共识（2017版）" target=_blank>中国冠状动脉杂交血运重建专家共识（2017版）</a></li> 更多信息请点击：<a href="//m.capotfarm.com/guideline/list.do?q=%E5%8A%A8%E8%84%89" target=_blank>有关动脉更多指南</a></ul>, tagList=[TagDto(tagId=6195, tagName=外周动脉疾病)], categoryList=[CategoryDto(categoryId=92, categoryName=血管外科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=解读, guiderLanguage=0, guiderRegion=0, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=7725, appHits=356, showAppHits=0, pcHits=5347, showPcHits=2928, likes=119, shares=15, comments=9, approvalStatus=1, publishedTime=Tue Jan 23 21:46:33 CST 2018, publishedTimeString=2017-12-30, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Tue Jan 23 21:46:33 CST 2018, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 22:07:09 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2017年ESC外周动脉疾病诊断治疗指南解读—下肢动脉疾病篇)])
2017年ESC外周动脉疾病诊断治疗指南解读—下肢动脉疾病篇
下载请点击：
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=912907, encodeId=522c91290e0e, content=特别好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKj1Mo1VnTZ4wxFFcwh6RcnbDibOiboQVMfCthUBicyYBY030PBhQiboE0pftbkQvxV0IbAaIvyNoCTIw/132, createdBy=76da2468967, createdName=ms5000968347304471, createdTime=Fri Jan 01 17:38:19 CST 2021, time=2021-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=912906, encodeId=0fe4912906ef, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKj1Mo1VnTZ4wxFFcwh6RcnbDibOiboQVMfCthUBicyYBY030PBhQiboE0pftbkQvxV0IbAaIvyNoCTIw/132, createdBy=76da2468967, createdName=ms5000968347304471, createdTime=Fri Jan 01 17:38:13 CST 2021, time=2021-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=333701, encodeId=ff75333e01f1, content=好好好，谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=981b2401455, createdName=12355bb4m53(暂无昵称), createdTime=Mon Jul 23 23:10:33 CST 2018, time=2018-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=331978, encodeId=9cd13319e879, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/15/25e88f12cfb4d0732d8f788d37a60453.jpg, createdBy=41472195395, createdName=120a1bf7m91暂无昵称, createdTime=Mon Jul 16 11:31:56 CST 2018, time=2018-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=282298, encodeId=418f2822989e, content=henhao, beContent=null, objectType=guider, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a9d2256316, createdName=1217549fm29暂无昵称, createdTime=Fri Jan 26 21:53:57 CST 2018, time=2018-01-26, status=1, ipAttribution=)]
    2021-01-01 ms5000968347304471

    特别好

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=912907, encodeId=522c91290e0e, content=特别好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKj1Mo1VnTZ4wxFFcwh6RcnbDibOiboQVMfCthUBicyYBY030PBhQiboE0pftbkQvxV0IbAaIvyNoCTIw/132, createdBy=76da2468967, createdName=ms5000968347304471, createdTime=Fri Jan 01 17:38:19 CST 2021, time=2021-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=912906, encodeId=0fe4912906ef, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKj1Mo1VnTZ4wxFFcwh6RcnbDibOiboQVMfCthUBicyYBY030PBhQiboE0pftbkQvxV0IbAaIvyNoCTIw/132, createdBy=76da2468967, createdName=ms5000968347304471, createdTime=Fri Jan 01 17:38:13 CST 2021, time=2021-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=333701, encodeId=ff75333e01f1, content=好好好，谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=981b2401455, createdName=12355bb4m53(暂无昵称), createdTime=Mon Jul 23 23:10:33 CST 2018, time=2018-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=331978, encodeId=9cd13319e879, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/15/25e88f12cfb4d0732d8f788d37a60453.jpg, createdBy=41472195395, createdName=120a1bf7m91暂无昵称, createdTime=Mon Jul 16 11:31:56 CST 2018, time=2018-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=282298, encodeId=418f2822989e, content=henhao, beContent=null, objectType=guider, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a9d2256316, createdName=1217549fm29暂无昵称, createdTime=Fri Jan 26 21:53:57 CST 2018, time=2018-01-26, status=1, ipAttribution=)]
    2021-01-01 ms5000968347304471

    非常好

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=912907, encodeId=522c91290e0e, content=特别好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKj1Mo1VnTZ4wxFFcwh6RcnbDibOiboQVMfCthUBicyYBY030PBhQiboE0pftbkQvxV0IbAaIvyNoCTIw/132, createdBy=76da2468967, createdName=ms5000968347304471, createdTime=Fri Jan 01 17:38:19 CST 2021, time=2021-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=912906, encodeId=0fe4912906ef, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKj1Mo1VnTZ4wxFFcwh6RcnbDibOiboQVMfCthUBicyYBY030PBhQiboE0pftbkQvxV0IbAaIvyNoCTIw/132, createdBy=76da2468967, createdName=ms5000968347304471, createdTime=Fri Jan 01 17:38:13 CST 2021, time=2021-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=333701, encodeId=ff75333e01f1, content=好好好，谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=981b2401455, createdName=12355bb4m53(暂无昵称), createdTime=Mon Jul 23 23:10:33 CST 2018, time=2018-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=331978, encodeId=9cd13319e879, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/15/25e88f12cfb4d0732d8f788d37a60453.jpg, createdBy=41472195395, createdName=120a1bf7m91暂无昵称, createdTime=Mon Jul 16 11:31:56 CST 2018, time=2018-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=282298, encodeId=418f2822989e, content=henhao, beContent=null, objectType=guider, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a9d2256316, createdName=1217549fm29暂无昵称, createdTime=Fri Jan 26 21:53:57 CST 2018, time=2018-01-26, status=1, ipAttribution=)]
    2018-07-23 12355bb4m53(暂无昵称)

    好好好，谢谢分享

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=912907, encodeId=522c91290e0e, content=特别好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKj1Mo1VnTZ4wxFFcwh6RcnbDibOiboQVMfCthUBicyYBY030PBhQiboE0pftbkQvxV0IbAaIvyNoCTIw/132, createdBy=76da2468967, createdName=ms5000968347304471, createdTime=Fri Jan 01 17:38:19 CST 2021, time=2021-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=912906, encodeId=0fe4912906ef, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKj1Mo1VnTZ4wxFFcwh6RcnbDibOiboQVMfCthUBicyYBY030PBhQiboE0pftbkQvxV0IbAaIvyNoCTIw/132, createdBy=76da2468967, createdName=ms5000968347304471, createdTime=Fri Jan 01 17:38:13 CST 2021, time=2021-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=333701, encodeId=ff75333e01f1, content=好好好，谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=981b2401455, createdName=12355bb4m53(暂无昵称), createdTime=Mon Jul 23 23:10:33 CST 2018, time=2018-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=331978, encodeId=9cd13319e879, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/15/25e88f12cfb4d0732d8f788d37a60453.jpg, createdBy=41472195395, createdName=120a1bf7m91暂无昵称, createdTime=Mon Jul 16 11:31:56 CST 2018, time=2018-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=282298, encodeId=418f2822989e, content=henhao, beContent=null, objectType=guider, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a9d2256316, createdName=1217549fm29暂无昵称, createdTime=Fri Jan 26 21:53:57 CST 2018, time=2018-01-26, status=1, ipAttribution=)]
    2018-07-16 120a1bf7m91暂无昵称

    受益匪浅

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=912907, encodeId=522c91290e0e, content=特别好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKj1Mo1VnTZ4wxFFcwh6RcnbDibOiboQVMfCthUBicyYBY030PBhQiboE0pftbkQvxV0IbAaIvyNoCTIw/132, createdBy=76da2468967, createdName=ms5000968347304471, createdTime=Fri Jan 01 17:38:19 CST 2021, time=2021-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=912906, encodeId=0fe4912906ef, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKj1Mo1VnTZ4wxFFcwh6RcnbDibOiboQVMfCthUBicyYBY030PBhQiboE0pftbkQvxV0IbAaIvyNoCTIw/132, createdBy=76da2468967, createdName=ms5000968347304471, createdTime=Fri Jan 01 17:38:13 CST 2021, time=2021-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=333701, encodeId=ff75333e01f1, content=好好好，谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=981b2401455, createdName=12355bb4m53(暂无昵称), createdTime=Mon Jul 23 23:10:33 CST 2018, time=2018-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=331978, encodeId=9cd13319e879, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/15/25e88f12cfb4d0732d8f788d37a60453.jpg, createdBy=41472195395, createdName=120a1bf7m91暂无昵称, createdTime=Mon Jul 16 11:31:56 CST 2018, time=2018-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=282298, encodeId=418f2822989e, content=henhao, beContent=null, objectType=guider, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a9d2256316, createdName=1217549fm29暂无昵称, createdTime=Fri Jan 26 21:53:57 CST 2018, time=2018-01-26, status=1, ipAttribution=)]
    2018-01-26 1217549fm29暂无昵称

    henhao

    0

Baidu
map
Baidu
map
Baidu
map